Search company, investor...
IlluminOss Medical company logo

IlluminOss Medical

illuminoss.com

Founded Year

2007

Stage

Acq - Fin | Acquired

Total Raised

$62.49M

About IlluminOss Medical

IlluminOss Medical is a medical device company dedicated to the development of minimally invasive orthopedic systems for the stabilization and treatment of bone fractures. The company's proprietary technology, the IlluminOss System, utilizes a photodynamic polymer system designed to eliminate the need for traditional methods of bone fixation with external pins, plates and screws.

Headquarters Location

993 Waterman Avenue

East Providence, Rhode Island, 02914,

United States

401-714-0008

Missing: IlluminOss Medical's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: IlluminOss Medical's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing IlluminOss Medical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

IlluminOss Medical is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

11,877 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,901 items

IlluminOss Medical Patents

IlluminOss Medical has filed 1 patent.

The 3 most popular patent topics include:

  • Bone fractures
  • Orthopedic surgical procedures
  • Skeletal system
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/9/2021

8/23/2022

Bone fractures, Orthopedic surgical procedures, Traumatology, Surgical removal procedures, Surgery

Grant

Application Date

7/9/2021

Grant Date

8/23/2022

Title

Related Topics

Bone fractures, Orthopedic surgical procedures, Traumatology, Surgical removal procedures, Surgery

Status

Grant

Latest IlluminOss Medical News

IlluminOss receives FDA clearance for photodynamic bone stabilization system

Jul 26, 2020

Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Please try again later. If you continue to have this issue please contact customerservice@slackinc.com . Back to Healio IlluminOss Medical has received FDA 510(k) clearance for the clinical use of its photodynamic bone stabilization system, according to a company press release. The system, which utilizes a patient-specific intramedullary implant, is designed for the treatment of pelvic, clavicle and small bone fractures, such a metacarpals, metatarsals and phalanges. It also deploys a liquid polymer inside an expandable balloon to create a rigid implant within the bone canal, according to the release. “The new indication expansion significantly broadens the opportunities to address the geriatric fragility fracture market where patients often have poor bone quality,” Robert Rabiner, IlluminOss chief technology officer, said in the release. “An example would be fractures of the pelvis; IlluminOss is deployed through a small, minimally invasive, tissue-sparing incision. Our system conforms to the curvature of the pelvis, and in a simple procedure provides strength and stability to the fracture. Surgeons report their patients have a rapid return to function, which is crucial for this patient population, as well as significant reduction in the use of postoperative opioids,” he added.

IlluminOss Medical Frequently Asked Questions (FAQ)

  • When was IlluminOss Medical founded?

    IlluminOss Medical was founded in 2007.

  • Where is IlluminOss Medical's headquarters?

    IlluminOss Medical's headquarters is located at 993 Waterman Avenue, East Providence.

  • What is IlluminOss Medical's latest funding round?

    IlluminOss Medical's latest funding round is Acq - Fin.

  • How much did IlluminOss Medical raise?

    IlluminOss Medical raised a total of $62.49M.

  • Who are the investors of IlluminOss Medical?

    Investors of IlluminOss Medical include HealthpointCapital, EQT Life Sciences, SR One, Flare Capital Partners, Excel Venture Management and 7 more.

  • Who are IlluminOss Medical's competitors?

    Competitors of IlluminOss Medical include Monteris Medical, FloShield, Myomo, Intact Medical, Symetis and 16 more.

Compare IlluminOss Medical to Competitors

F
FloShield

FloShield is a family of products that improve visualization during laparoscopic surgery. It was founded in 2009 and is based in Cupertino, California.

N
NICO

NICO develops technology for the field of minimally invasive neurosurgery, including skull base and spinal surgery. The company's technology and products are designed and developed to impact patients' lives, families, caregivers, and health system providers. It provides patented technologies that integrate imaging and intervention for approaches to brain surgery. NICO was founded in 2007 and is based in Indianapolis, Indiana.

C
Coromedic

Coromedic is a privately owned biomedical start up company working to manufacture devices and develop techniques to facilitate coronary artery bypass surgery in a minimally invasive technique. The company's flagship products, the proximal anastomosis device, the distal anastomosis device and the internal mammary artery harvester are a in a set of invaluable tools aimed at easing the complications associated with the conventional surgery. The company have worked to design and build prototypes of the company's products and develop a business strategy, consulting with numerous professionals to assess the feasibility and utility of the company's product and business model. The process of idea protection and patent application is ongoing, a provisional patent for one of the company's products, the proximal anastomosis devices is in place and the application for patent protection of all the company's products is underway. The prototype of the company's first device, the proximal anastomosis device is built and tested in the wet lab. The company are currently working on prototype assembly of the company's second and third products, after which lab animal experiments in the appropriate facilities will take place and then approval for clinical trials and their undertaking will commence.

A
Advanced Biosurfaces

ABS Corporation designs and develops minimally invasive technology focused on relieving pain in the knee. Two medial knee implant systems have been developed: The PEEK Mobility Medial Knee Implant and the OrthoGlide Medial Knee Implant.

A
Axis Surgical Technologies

Axis Surgical Technologies, Inc. aims to develop, manufacture, and market devices that improve quality and efficiency in spinal surgery, especially for minimally invasive surgical techniques. Based in Mountain View, California, Axis offers an integration of visualization and articulation capabilities and provides spinal surgery equipment.Axis' FDA Grant In March 2010, Axis announced that it received 510(k) clearance from the Food and Drug Administration to market its C-MOR„ Visualization Device to use in diagnostic and operative arthroscopic and endoscopic procedures. This portable tool provides visualization and illumination of an interior cavity through either a natural or surgical opening. The ergonomic lightweight device also offers practitioners the convenience of endoscopic visualization and efficient one-handed operating ability; this device can be employed in hospital outpatient departments, ambulatory surgery centers, and office surgery suites.

N
Neurosonix

NeuroSonix is an Israeli medical device company targeting the market of cerebral embolic protection during cardiac surgical and other minimally invasive procedures. NeuroSonix has conceived, developed and patented a technology and medical devices for the prevention of acute cerebral embolism during open-heart cardiac surgery as well as other invasive and minimally-invasive procedures. The company's technology, which is based on ultrasound, aims to enable a non-invasive deflection of embolic material flowing inside the body, away from the cerebral arteries. This new ultrasonic modality aims to reduce the embolic load on the patient's brain. The first product developed by the company is the EmBlocker"ž, intended to provide protection from acute cerebral embolism during cardiac surgical procedures. The Protection Collar, the company's second product, is intended for embolic protection during minimally-invasive procedures and Cath-lab practice.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.